Loading...
News Category – Vivo News2019-10-20T17:42:02-07:00

Categories

Ascendis Pharma Announces Formation of VISEN Pharmaceuticals to Develop and Commercialize TransCon™ Endocrinology Rare Disease Therapies in China

November 8th, 2018|